BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yue C, Ren Y, Ge H, Yan L, Xu Y, Wang G, Wu J. Pseudogene DUXAP10 can be used as a diagnostic and prognostic biomarker in human cancers. J Cell Physiol 2019;234:23685-94. [DOI: 10.1002/jcp.28937] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Nsengimana B, Khan FA, Awan UA, Wang D, Fang N, Wei W, Zhang W, Ji S. Pseudogenes and Liquid Phase Separation in Epigenetic Expression. Front Oncol 2022;12:912282. [DOI: 10.3389/fonc.2022.912282] [Reference Citation Analysis]
2 Xu Y, Yu X, Sun Z, He Y, Guo W. Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC. Front Oncol 2022;12:831366. [PMID: 35356220 DOI: 10.3389/fonc.2022.831366] [Reference Citation Analysis]
3 Zeng R, Wang C, Wang W, Wang S. Long non-coding RNA DUXAP9 promotes hepatocellular carcinoma cell stemness via directly interacting with sox9. Environ Toxicol 2021;36:1793-801. [PMID: 34086387 DOI: 10.1002/tox.23300] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Ding Y, Liu N, Chen M, Xu Y, Fang S, Xiang W, Hua X, Chen G, Zhong Y, Yu H. Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA. World J Surg Oncol 2021;19:133. [PMID: 33888142 DOI: 10.1186/s12957-021-02231-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Du Y, Gao Y. Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma. BMC Cancer 2020;20:887. [PMID: 32938429 DOI: 10.1186/s12885-020-07391-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Li J, Jiang L, Liu Z, Li Y, Xu Y, Liu H. Oncogenic pseudogene DUXAP10 knockdown suppresses proliferation and invasion and induces apoptosis of papillary thyroid carcinoma cells by inhibition of Akt/mTOR pathway. Clin Exp Pharmacol Physiol 2020;47:1473-83. [PMID: 32215944 DOI: 10.1111/1440-1681.13310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
7 Yue C, Liang C, Li P, Yan L, Zhang D, Xu Y, Wei Z, Wu J. DUXAP8 a Pan-Cancer Prognostic Marker Involved in the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation. Onco Targets Ther 2019;12:11637-50. [PMID: 32021243 DOI: 10.2147/OTT.S231750] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]